APC/Cyanine7 anti-mouse/human CD11b Antibody

Pricing & Availability
Clone
M1/70 (See other available formats)
Regulatory Status
RUO
Other Names
αM integrin, Mac-1, Mo1, CR3, Ly-40, C3biR, ITGAM
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
M1slash70_APCCy7_021808
C57BL/6 mouse bone marrow stained with M1/70 APC/Cyanine7
  • M1slash70_APCCy7_021808
    C57BL/6 mouse bone marrow stained with M1/70 APC/Cyanine7
Compare all formats See APC/Cyanine7 spectral data
Cat # Size Price Save
101225 25 µg ¥16,740
101226 100 µg ¥38,450
Description

CD11b is a 170 kD glycoprotein also known as αM integrin, Mac-1 α subunit, Mol, CR3, and Ly-40. CD11b is a member of the integrin family, primarily expressed on granulocytes, monocytes/macrophages, dendritic cells, NK cells, and subsets of T and B cells. CD11b non-covalently associates with CD18 (β2 integrin) to form Mac-1. Mac-1 plays an important role in cell-cell interaction by binding its ligands ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, and fibrinogen.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse, Human, Cynomolgus, Rhesus
Reported Reactivity
Chimpanzee, Baboon, Rabbit
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
C57BL/10 splenocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Clone M1/70 has been verified for immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F).

Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1,4, in vitro blocking3,9,12, depletion2,8, immunofluorescence microscopy6,7,10, immunohistochemistry of acetone-fixed frozen sections5,11-13, and spatial biology (IBEX)35,36. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) (Cat. No. 101248).

Additional Product Notes
BioLegend is in the process of converting the name APC/Cy7 to APC/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our APC/Cyanine7 products. Please contact Technical Service if you have any questions.
Application References

(PubMed link indicates BioLegend citation)
  1. Springer T, et al. 1978. Eur. J. Immunol. 8:539. (IP)
  2. Ault K and Springer T. 1981. J. Immunol. 126:359. (Deplete)
  3. Springer TA, et al. 1982. Immunol. Rev. 68:171. (Block)
  4. Ho MK and Springer TA. 1983. J. Biol. Chem. 258:2766. (IP)
  5. Flotte TJ, et al. 1983. Am. J. Pathol. 111:112. (IHC)
  6. Noel GJ, et al. 1990. J. Clin. Invest. 85:208. (IF)
  7. Allen LA and Aderem A. 1996. J. Exp. Med. 184:627 (IF)
  8. D'Amico A and Wu L. 2003. J. Exp. Med. 198:293. (Deplete)
  9. Brickson SJ, et al. 2003. Appl Physiol. 95:969. (Block)
  10. Clatworthy MR and Smith KG. 2004. J. Exp. Med. 199:717. (IF)
  11. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  12. Zhang Y, et al. 2002. J. Immunol. 168:3088. (IHC)
  13. Iwasaki A and Kelsall BL. 2001. J. Immunol. 166:4884 (IHC, FC)
  14. Tailleux L. 2003. J. Exp. Med. 197:121. (Block, FC)
  15. Olver S, et al. 2006. Cancer Research 66:571. (FC)
  16. Tan SL, et al. 2006. J. Immunol. 176:2872. (FC) PubMed
  17. Ponomarev ED, et al. 2006. J. Immunol. 176:1402. (FC)
  18. Dzhagalov I, et al. 2007. Blood 109:1620. (FC)
  19. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  20. Rasmussen JW, et al. 2006. Infect. Immun.74:6590. PubMed
  21. Napimoga MH, et al. 2008. J. Immunol. 180:609. PubMed
  22. Elqaraz-Carmon V, et al. 2008. J. Lipid. Res. 49:1894. PubMed
  23. Kim DD, et al. 2008. Blood 112:1109. PubMed
  24. Guo Y, et al. 2008. Blood 112:480. PubMed
  25. Norian LA, et al. 2009. Cancer Res. 69:3086. (FC) PubMed
  26. Baumgartner CK, et al. 2010. J. Immunol. 184:573. PubMed
  27. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  28. Whiteland J, et al. 1995. J. Histochem. Cytochem. 43:313. (IHC)
  29. Weber GF, et al. 2014. J Exp Med. 211:1243. PubMed
  30. Ashok A, et al. 2015. Toxicol Sci. 143:64. PubMed
  31. Price PJ, et al. 2015. J Immunol. 194:1164. PubMed
  32. Doni A, et al. 2015. J Exp Med. 212:905. PubMed
  33. Ferreira R, et al. 2016. J Infect Dis. 213: 669 - 673. PubMed
  34. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
  35. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  36. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Brown A, et al. 2012. Arterioscler Thromb Vasc Biol. 32:2122. PubMed
  2. Dixit N, et al. 2012. J Immunol. 189:5954. PubMed
  3. Wangdi T, et al. 2014. PLoS Pathog. 10:1004306. PubMed
  4. Chung Y, et al. 2014. J Vis Exp. 89: 51660. PubMed
  5. Daemen S, et al. 2021. Cell Reports. 34(2):108626. PubMed
  6. Sweet R, et al. 2017. J Immunol. 10.4049/jimmunol.1600861. PubMed
  7. Filipello F et al. 2018. Immunity. 48(5):979-991 . PubMed
  8. Mathur R, et al. 2019. Mucosal Immunol. 12:612. PubMed
  9. Miragaia RJ, et al. 2019. Immunity. 50:493. PubMed
  10. Casellas Roman HL, et al. 2020. Leuk Res. 94:106372. PubMed
  11. Yokozeki Y, et al. 2021. Biomed Res Int. 2021:7988320. PubMed
  12. Hutter K, et al. 2022. Front Immunol. 13:967914. PubMed
  13. Garcia-Fabiani MB, et al. 2020. Methods Enzymol. 632:369. PubMed
  14. Viny AD, et al. 2019. Cell Stem Cell. 25:682. PubMed
  15. Zhou J, et al. 2019. Immunity. 50:403. PubMed
  16. Fachi JL et al. 2019. Cell reports. 27(3):750-761 . PubMed
  17. Cho SM et al. 2018. Journal of neurochemistry. 148(5):625-638 . PubMed
  18. Yang N, et al. 2022. NPJ Vaccines. 7:120. PubMed
  19. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  20. Golden GJ, et al. 2021. MBio. 12:e0118121. PubMed
  21. Schönberger K, et al. 2022. Cell Stem Cell. 29:131. PubMed
  22. Nguyen NDNT, et al. 2020. NPJ Vaccines. 5:7. PubMed
  23. Larson-Casey JL, et al. 2021. FASEB J. 35:e21675. PubMed
  24. Savio LEB, et al. 2020. J Cell Sci. 133:jcs237560. PubMed
  25. Gattas MJ, et al. 2021. International Journal of Molecular Sciences. 22(10):. PubMed
  26. Yilmaz B, et al. 2021. Cell Host Microbe. 29(4):650-663.e9. PubMed
  27. Clarke F,et al. 2017. PLoS One. 10.1371/journal.pone.0186625. PubMed
  28. Giambra V et al. 2018. Cell stem cell. 23(5):714-726 . PubMed
  29. Lino AC et al. 2018. Immunity. 49(1):120-133 . PubMed
  30. Zhang K, et al. 2018. PLoS Pathog. 14:e1006925. PubMed
  31. Delás MJ, et al. 2019. Cell Rep. 27:719. PubMed
  32. Kashyap AS, et al. 2019. Cell Rep. 28:3367. PubMed
  33. Yang M, et al. 2020. Cell Prolif. 53:e12784. PubMed
  34. Sakamoto T, et al. 2021. Commun Biol. 4:1165. PubMed
  35. Chen S, et al. 2022. Cancer Discov. :. PubMed
  36. Jenull S, et al. 2021. Cell Reports. 36(3):109406. PubMed
  37. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  38. Liang W, et al. 2020. Nat Commun. 4.563888889. PubMed
  39. Clement M, et al. 2016. PLoS Pathog. 12:e1006050. PubMed
  40. Billroth-MacLurg, AC, et al. 2016. J Immunol. 197:2208-2218. PubMed
  41. Eastman A, et al. 2016. J Immunol . 194: 5999-6010. PubMed
  42. Zasłona Z, et al. 2014. J Immunol. 193:4245. PubMed
  43. Spees A, et al. 2013. MBio. 2:430. PubMed
  44. Harel M, et al. 2020. Cell. 179(1):236-250.e18.. PubMed
  45. Li Y, et al. 2020. Cell Rep. 30:1753. PubMed
  46. Wong E, et al. 2019. Cell Rep. 29:3047. PubMed
  47. Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed
  48. Achmus L, et al. 2020. Front Neurol. 11:577971. PubMed
  49. Nagatake T, et al. 2022. Mucosal Immunol. 15:289. PubMed
  50. Leimkühler NB, et al. 2020. Cell Stem Cell. 28:637. PubMed
  51. Getts D, et al. 2014. Sci Transl Med. 15:219. PubMed
  52. Tanaka Y, et al. 2015. PLoS One. 10: 0138621. PubMed
  53. Palamides P, et al. 2016. Dis Model Mech. 9: 985 - 997. PubMed
  54. Wang H, et al. 2019. Immunotherapy. 11:101. PubMed
  55. Davis FM, et al. 2019. Arterioscler Thromb Vasc Biol. 39:2353. PubMed
  56. Di Gioia M, et al. 2020. Nat Immunol. 21:42. PubMed
  57. Kleinholz CL, et al. 2021. Sci Rep. 11:15071. PubMed
  58. Inoue D, et al. 2021. Nat Genet. 53:707. PubMed
  59. Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed
  60. Enriquez AB, et al. 2022. iScience. 25:104305. PubMed
  61. Yang F, et al. 2020. Cancer Res. 80:3677. PubMed
  62. Hoffman D, et al. 2021. Immunity. 54:2712. PubMed
  63. Diao N, et al. 2016. Sci Rep. 6:34672. PubMed
  64. Krueger K, et al. 2014. Stem Cell Reports. 9:1147. PubMed
  65. Saika A, et al. 2020. FASEB Bioadv. 2:59. PubMed
  66. Bhattacherjee A, et al. 2019. Commun Biol. 2:450. PubMed
  67. Yoshimi A, et al. 2019. Nature. 574:273. PubMed
  68. Mariani SA, et al. 2019. Immunity. 50:1439. PubMed
  69. Bhattacherjee A, et al. 2021. Mol Neurodegener. 16:19. PubMed
  70. Wang C, et al. 2021. Cell Rep. 37:110021. PubMed
  71. Stahlhut M, et al. 2021. Sci Rep. 11:5294. PubMed
  72. Gordon RA, et al. 2020. PLoS One. 15:e0226396. PubMed
  73. Glass A, et al. 2013. J Immunol. 190:4830. PubMed
  74. Kurkewich J, et al. 2016. PLoS One. 11: 0161468. PubMed
  75. Jeljeli M, et al. 2020. Cell Rep. 33:108325. PubMed
  76. Hagan AS, et al. 2020. Development. 147:00:00. PubMed
  77. Wei SC, et al. 2020. Cancer Discov. . PubMed
  78. Dos Santos Dias L, et al. 2021. PLoS Pathog. e1009324:17. PubMed
  79. Kunimoto H, et al. 2018. Cancer Cell. 33:44. PubMed
  80. Perry JSA, et al. 2018. Immunity. 48:923. PubMed
  81. Parlet CP, et al. 2019. Cell Rep. 27:187. PubMed
  82. Zhang S, et al. 2019. Cell Metab. 29:443. PubMed
  83. Davidson S, et al. 2020. Cell Reports. 31(7):107628. PubMed
  84. García-Bonilla M, et al. 2020. Stem Cell Res Ther. 11:121. PubMed
  85. Goggi JL, et al. 2020. Mol Imaging Biol. 22:1392. PubMed
  86. Zhang X, et al. 2022. Theranostics. 12:1621. PubMed
  87. Enriquez AB, et al. 2022. iScience. 25:104305. PubMed
  88. Wu X, et al. 2021. Elife. 10:. PubMed
  89. Wang B, et al. 2022. Nat Commun. 13:3821. PubMed
  90. Jiang N, et al. 2022. Nat Commun. 13:1511. PubMed
  91. Kirschbaum K, et al. 2016. Proc Natl Acad Sci U S A. 113: 13227 - 13232. PubMed
  92. Ano Y, et al. 2017. J Biol Chem. 292:3720. PubMed
  93. Cong J et al. 2018. Cell metabolism. 28(2):243-255 . PubMed
  94. Kleppe M et al. 2018. Cancer cell. 33(1):29-43 . PubMed
  95. Yang L, et al. 2021. Cell Death Differ. 28:2616. PubMed
  96. McAlpine CS, et al. 2021. Nature. 595:701. PubMed
  97. Naler LB, et al. 2022. Commun Biol. 5:102. PubMed
  98. Kornstädt L, et al. 2021. Front Immunol. 11:607048. PubMed
  99. Hutter K, et al. 2020. FEBS J. . PubMed
  100. Zhao J, et al. 2018. Stem Cell Reports. 10:180. PubMed
  101. Mamedov MR, et al. 2018. Immunity. 48:350. PubMed
  102. Codina A, et al. 2019. Cell Syst. 8:136. PubMed
  103. Hulsmans M et al. 2017. Cell. 169(3):510-522 . PubMed
  104. Yu X, et al. 2020. Nat Commun. 0.641666667. PubMed
  105. Kobayashi M, et al. 2020. Bio Protoc. 10:e3601. PubMed
  106. Geng S, et al. 2021. JCI Insight. 6:. PubMed
  107. Formaglio P, et al. 2021. Immunity. 54:2724. PubMed
  108. Pan Y, et al. 2022. J Clin Invest. 132:. PubMed
  109. Zhu Y, et al. 2022. Clin Transl Med. 12:e887. PubMed
  110. Feng S, et al. 2022. Front Immunol. 13:990522. PubMed
  111. Witkowski MT, et al. 2020. Cancer Cell. 37:867. PubMed
  112. Hu Y, et al. 2021. Bioact Mater. 2905:6. PubMed
  113. Mulas F, et al. 2020. Cell Mol Immunol. . PubMed
  114. McFarland AP, et al. 2021. Immunity. 54(6):1320-1337.e4. PubMed
  115. Kenswil KJG, et al. 2021. Cell Stem Cell. 28(4):653-670.e11. PubMed
  116. Zhang C, et al. 2020. Cell Rep. 32:108206. PubMed
  117. Mishra BB, et al. 2017. Nat Microbiol. 2:17072. PubMed
  118. Niknam S, et al. 2018. Clin Cancer Res. 24:5735. PubMed
  119. Vicencio JM, et al. 2022. Cell Death Dis. 13:274. PubMed
  120. , et al. 2021. Eur J Immunol. 51:2708. PubMed
  121. Pradhan K, et al. 2021. Front Immunol. 12:778830. PubMed
  122. Panea C, et al. 2021. Commun Biol. 4:913. PubMed
  123. Guldner IH, et al. 2020. Cell. 183(5):1234-1248.e25. PubMed
  124. Lim CX, et al. 2020. Cell Rep. 3793:30. PubMed
  125. Martínez‐López M et al. 2019. Immunity. 50(2):446-461 . PubMed
  126. Casulli J, et al. 2019. Nat Commun. 10:2121. PubMed
  127. Xiong X et al. 2019. Mol Cell. 75(3):644-660 . PubMed
  128. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  129. Pietronigro E, et al. 2019. Sci Rep. 9:12055. PubMed
  130. Pfefferlé M, et al. 2021. Front Immunol. 12:680855. PubMed
  131. Ma S, et al. 2022. Cell Rep. 38:110520. PubMed
  132. Unudurthi SD, et al. 2020. Life Sci. 117440:247. PubMed
  133. Yi W, et al. 2021. Cell Reports. 34(13):108922. PubMed
  134. Murakami K, et al. 2021. Cell Reports. 34(1):108579. PubMed
  135. LM S, et al. 2016. Cell Rep. 16(12): 3286-96. PubMed
  136. Lammers K, et al. 2015. PLoS One. 10: 0138338. PubMed
  137. Ermert D, et al. 2016. PLoS Pathog. 11: 1005043. PubMed
  138. Choi EW, et al. 2020. Sci Rep. 10:12001. PubMed
  139. Crane A, et al. 2018. Alzheimers Dement. 14:243. PubMed
  140. Chen Z, et al. 2019. J Exp Med. 216:152. PubMed
  141. Nagatake T, et al. 2018. Int Immunol. 30:471. PubMed
  142. Landon J Edgar et al. 2018. Cell chemical biology. 26(1):131-136 . PubMed
  143. Liu S, et al. 2018. Front Immunol. 29:208. PubMed
  144. Yang S, et al. 2022. J Exp Med. 219:. PubMed
  145. Cheresh P, et al. 2020. Int J Mol Sci. 21:. PubMed
  146. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  147. Larson-Casey JL, et al. 2021. J Biol Chem. :100810. PubMed
  148. San Gil R, et al. 2021. Cells. 10: . PubMed
  149. Yabas M, et al. 2016. PLoS One. 11: 0146774. PubMed
  150. Wu X, et al. 2016. Sci Rep. 6:18685. PubMed
  151. Savio LEB, et al. 2020. J Cell Sci. 133:00:00. PubMed
  152. Li CJ, et al. 2018. J Clin Invest. 128:5251. PubMed
  153. Goldstein JM et al. 2019. Cell reports. 27(4):1254-1264 . PubMed
  154. Li B, et al. 2019. Oncol Rep. 41:608. PubMed
  155. Carestia A, et al. 2019. Cell Rep. 28:896. PubMed
  156. Daemen S, et al. 2021. STAR Protoc. 2:100511. PubMed
  157. Shibad V, et al. 2021. Front Immunol. 12:722451. PubMed
  158. Zhang X, et al. 2021. Mol Cancer Res. 19:1076. PubMed
  159. Robles-Oteiza C, et al. 2021. Dis Model Mech. 14:. PubMed
  160. Gómez LA, et al. 2020. Front Microbiol. 11:1586. PubMed
  161. Xu X, et al. 2022. EMBO Rep. 23:e53509. PubMed
  162. Taya M, et al. 2020. Endocr Relat Cancer. 27:261. PubMed
  163. Hirata SI, et al. 2020. Allergy. 75:1939. PubMed
  164. Larson-Casey JL, et al. 2020. PLoS One. 15:e0241323. PubMed
  165. Kim M, et al. 2018. Immunity. 49:151. PubMed
  166. Nowak W, et al. 2020. EBioMedicine. 50:290-305.. PubMed
  167. Nagatake T, et al. 2018. J Allergy Clin Immunol. 142:470. PubMed
  168. Qiao S, et al. 2019. J Neuroinflammation. 16:4. PubMed
  169. Duarte D, et al. 2018. Cell Stem Cell. 22:64. PubMed
  170. Sia J, et al. 2017. PLoS Pathog.. 10.1371/journal.ppat.1006530. PubMed
  171. Zhang CR, et al. 2022. Blood Cancer Discov. 3:220. PubMed
  172. Anderson-Baucum E, et al. 2021. Cell Metab. 33:1883. PubMed
  173. Mendelsohn AC, et al. 2020. Am J Physiol Cell Physiol. 319:C997. PubMed
  174. King R, et al. 2021. Sci Adv. 7:eabj5293. PubMed
  175. Murdock BJ, et al. 2021. JCI Insight. 6:. PubMed
  176. Celik H, et al. 2018. Cancer Cell. 34:741. PubMed
  177. Yin S et al. 2019. Cancer cell. 35(2):283-296 . PubMed
  178. Zhao Y, et al. 2020. Immunity. 51(6):1059-1073.e9.. PubMed
  179. Soncin I, et al. 2018. Nat Commun. 9:582. PubMed
  180. Bhatt D, et al. 2021. J Exp Med. 218:. PubMed
  181. Karolin A, et al. 2022. Front Pharmacol. 12:789080. PubMed
  182. Gao Z, et al. 2022. J Inflamm Res. 15:3337. PubMed
  183. Jing Y, et al. 2021. Front Immunol. 12:651860. PubMed
  184. Tomimatsu M, et al. 2022. Sci Rep. 12:16656. PubMed
  185. Wang Z, et al. 2020. J Cell Mol Med. . PubMed
  186. Dallari S, et al. 2021. Cell Host Microbe. 29(6):1014-1029.e8. PubMed
  187. Rustenhoven J, et al. 2021. Cell. 184(4):1000-1016.e27. PubMed
  188. Flores AM, et al. 2020. Nat Nanotechnol. 0.731944444. PubMed
  189. McKenzie MD, et al. 2019. Cell Stem Cell. 25:258. PubMed
  190. Tulyeu J, et al. 2021. Curr Protoc. 1:e283. PubMed
  191. Zhang W, et al. 2021. Front Immunol. 12:768435. PubMed
  192. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  193. Hoyer FF, et al. 2020. Immunity. 51(5):899-914.e7.. PubMed
  194. Pradhan K, et al. 2021. J Immunol. 206:2980. PubMed
  195. Smith KJ, et al. 2022. PLoS Biol. 20:e3001554. PubMed
  196. Zhang L, et al. 2021. Front Mol Biosci. 8:647647. PubMed
  197. Liu Q, et al. 2021. Adv Mater. 33:e2102852. PubMed
  198. Lin R, et al. 2022. Cell Death Dis. 13:345. PubMed
  199. Luo X, et al. 2021. Neuron. 109:2691. PubMed
  200. Siolas D, et al. 2021. Cell Reports. 36:109578. PubMed
  201. Aryal B, et al. 2016. Nat Commun. 7:12313. PubMed
  202. Lee MC, et al. 2017. J Immunol. 198:3565. PubMed
  203. Säwen P et al. 2018. eLife. 7 pii: e41258. PubMed
  204. Luo H, et al. 2019. Cell Rep. 26:945. PubMed
  205. Fite BZ, et al. 2021. Sci Rep. 11:927. PubMed
  206. Schmit T, et al. 2022. Cell Rep. 38:110456. PubMed
  207. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  208. Chavkin NW, et al. 2021. J Am Heart Assoc. 10:e019904. PubMed
  209. Das A, et al. 2020. J Bone Miner Res. 36:199. PubMed
  210. Li A, et al. 2018. Cancer Lett. 431:54. PubMed
  211. Larson–Casey JL, et al. 2019. J Clin Invest. 129:4962. PubMed
  212. Zheng C, et al. 2021. J Extracell Vesicles. 10:e12109. PubMed
  213. Park HJ, et al. 2021. Int J Mol Sci. 22:. PubMed
  214. Wang X, et al. 2021. Sci Transl Med. 13:. PubMed
  215. Lau A, et al. 2022. Sci Adv. 8:eabm0142. PubMed
  216. Lippeveld M, et al. 2020. Cytometry A. 97:308. PubMed
  217. Avgustinova A, et al. 2021. Cell Stem Cell. . PubMed
  218. Cortez MA, et al. 2020. Nat Commun. 3.819444444. PubMed
  219. C Khouili S, et al. 2020. Cell Rep. 33:108468. PubMed
  220. Geng S, et al. 2016. Nat Commun. 7:13436. PubMed
  221. Denk F, et al. 2016. Cell Rep. 15: 1771-1781. PubMed
  222. Richardson M, et al. 2014. PLoS Negl Trop Dis. 8:2825. PubMed
  223. Ge Y, et al. 2020. Mucosal Immunol. 13:34. PubMed
  224. Cabal-Hierro L, et al. 2020. Nat Commun. 11:1406. PubMed
  225. Syed I et al. 2018. Cell metabolism. 27(2):419-427 . PubMed
  226. Patterson DG, et al. 2021. J Immunol. 207:1798. PubMed
RRID
AB_830641 (BioLegend Cat. No. 101225)
AB_830642 (BioLegend Cat. No. 101226)

Antigen Details

Structure
Integrin family, associates with integrin β2 (CD18), 170 kD
Distribution

Granulocytes, monocytes/macrophages, dendritic cells, NK cells, subsets of T and B cells

Function
Adhesion, chemotaxis
Ligand/Receptor
ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, fibrinogen
Cell Type
B cells, Dendritic cells, Granulocytes, Macrophages, Monocytes, Neutrophils, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Coxon A, et al. 1996. Immunity 5:653.

Gene ID
16409 View all products for this Gene ID 3684 View all products for this Gene ID
UniProt
View information about CD11b on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD11b Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse/human CD11b M1/70 FC
Biotin anti-mouse/human CD11b M1/70 FC
FITC anti-mouse/human CD11b M1/70 FC
PE anti-mouse/human CD11b M1/70 FC,IHC
PE/Cyanine5 anti-mouse/human CD11b M1/70 FC
Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,IHC-F,ICC
PE/Cyanine7 anti-mouse/human CD11b M1/70 FC
Alexa Fluor® 488 anti-mouse/human CD11b M1/70 FC,IHC-F,3D IHC,SB
Alexa Fluor® 647 anti-mouse/human CD11b M1/70 FC,3D IHC,SB
Alexa Fluor® 700 anti-mouse/human CD11b M1/70 FC
Pacific Blue™ anti-mouse/human CD11b M1/70 FC
APC/Cyanine7 anti-mouse/human CD11b M1/70 FC
PerCP/Cyanine5.5 anti-mouse/human CD11b M1/70 FC
PerCP anti-mouse/human CD11b M1/70 FC
Brilliant Violet 421™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 570™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 605™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 650™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 711™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 785™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 510™ anti-mouse/human CD11b M1/70 FC,ICC
Ultra-LEAF™ Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,Block,Depletion,IHC-F,ICC
Purified anti-mouse/human CD11b (Maxpar® Ready) M1/70 FC,CyTOF®
Alexa Fluor® 594 anti-mouse/human CD11b M1/70 IHC-F,FC
PE/Dazzle™ 594 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 750 anti-mouse/human CD11b M1/70 FC
TotalSeq™-A0014 anti-mouse/human CD11b M1/70 PG
Brilliant Violet 750™ anti-mouse/human CD11b M1/70 FC
TotalSeq™-B0014 anti-mouse/human CD11b M1/70 PG
TotalSeq™-C0014 anti-mouse/human CD11b M1/70 PG
Spark NIR™ 685 anti-mouse/human CD11b M1/70 FC
PE/Fire™ 640 anti-mouse/human CD11b M1/70 FC
Spark YG™ 593 anti-mouse/human CD11b M1/70 FC
Spark YG™ 570 anti-mouse/human CD11b M1/70 IHC-F
PE/Fire™ 810 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 810 anti-mouse/human CD11b Antibody M1/70 FC
Spark Blue™ 550 anti-mouse/human CD11b M1/70 FC
Spark UV™ 387 anti-mouse/human CD11b M1/70 FC
PerCP/Fire™ 806 anti-mouse/human CD11b M1/70 FC
PerCP/Fire™ 780 anti-mouse/human CD11b M1/70 FC
Spark Blue™ 574 anti-mouse/human CD11b (Flexi-Fluor™) M1/70 FC
Spark PLUS UV™ 395 anti-mouse/human CD11b M1/70 FC
Go To Top Version: 1    Revision Date: 11/30/2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account